Showing results (491-500 of 525) with videos related to
Sort By:
Pageof 53
International Journal of Cancer|May 29, 1997
p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neckA G Scholes, T Liloglou, P J Snijders, et al.Journal of Thrombosis and Haemostasis : JTH|November 16, 2024
Biophysical characterization of blood coagulation factor VIII binding to lipid nanodiscs that mimic activated platelet surfacesNathan G Avery, Isabelle R Young, Selena Lu, et al.The Journal of Urology|October 31, 2006
Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysisD A Barocas, S M Rohan, J Kao, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase I/II trial of intravesical methotrexate for superficial bladder tumorsC N Sternberg, A Yagoda, N H Bander, et al.International Journal of Cancer|May 16, 1996
Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neckP J Snijders, A G Scholes, C A Hart, et al.Cancer Research|December 1, 1989
Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomasN H Bander, C L Finstad, C Cordon-Cardo, et al.Cancer|December 15, 1989
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseC N Sternberg, A Yagoda, H I Scher, et al.Journal of Membrane Science & Technology|July 25, 2015
Identification of the Transmembrane Glucose Regulated Protein 78 as a Biomarker for the Brain Cancer Glioblastoma Multiforme by Gene Expression and Proteomic StudiesH N Banerjee, G Hyman, S Evans, et al.Acta Oto-Laryngologica|May 1, 1987
A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancerJ B Campbell, E B Dorman, M McCormick, et al.Annals of Internal Medicine|December 1, 1994
Diagnosis and treatment of primary hyperaldosteronismJ D Blumenfeld, J E Sealey, Y Schlussel, et al.Pageof 53